Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.

We have analysed data on exacerbation rates, Expanded Disability Status Scale (EDSS) scores, and lesion burdens using the results of two neutralizing antibody (NAB) assays (CPE and MxA) from the pivotal relapsing-remitting multiple sclerosis (MS) trial of interferon beta-1b (IFNB) with a longitudina...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Petkau, A, White, R, Ebers, G, Reder, A, Sibley, W, Lublin, F, Paty, D
التنسيق: Journal article
اللغة:English
منشور في: 2004